Skip to content
Clinical Trials – home
Stoke Therapeutics Inc.
Sponsor

Stoke Therapeutics Inc.

United States 45 Wiggins Avenue, 01730-2314, United States

About the sponsor

Clinical research in Dravet syndrome with attention to major motor seizures, including hemiclonic seizures, focal seizures with motor signs, focal to bilateral tonic-clonic seizures, generalized tonic-clonic seizures, tonic seizures, tonic-atonic drop attacks, and bilateral clonic seizures.

  • Seizure frequency
  • Motor seizure control
  • Dravet syndrome

Research activity in this area is centered on therapeutic options for severe childhood-onset epileptic encephalopathy.

About Specializations

Stoke Therapeutics Inc. runs clinical trials in conditions such as Hereditary optic atrophy, Severe myoclonic epilepsy of infancy, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

2 clinical trials

Countries:AustriaAustria
  • Participants:0–17 years · 18–64 years
  • Substances:18‐Mer Antisense Oligonucleotide Complementary To Opa1 Pre-Mrna
  • Sponsor:Stoke Therapeutics Inc.
Countries:FranceFrance
  • Participants:0–17 years
  • Substances:ZOREVUNERSEN SODIUM
  • Sponsor:Stoke Therapeutics Inc.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.